Lisata Therapeutics

LSTA NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $0 $0 $0
Gross Profit -46 -47 -47 -48
EBITDA -6,555 -5,978 -6,631 -7,496
EBIT -6,601 -6,025 -6,678 -7,543
Net Income -5,401 -5,365 -5,261 -4,027
Net Change In Cash 0 0 0 0
Free Cash Flow -7,027 -4,069 -3,583 -4,184
Cash 21,805 22,593 32,428 23,690
Basic Shares 8,294 8,140 8,141 8,021

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $121,372 $0 $0
Gross Profit -189 63,771 -55 -63
EBITDA -25,519 -58,584 -29,146 -19,082
EBIT -25,708 -57,601 -29,050 -19,145
Net Income -20,840 -54,225 -27,466 -8,141
Net Change In Cash 0 121,372 0 0
Free Cash Flow -20,032 -21,455 -22,305 -8,843
Cash 22,593 32,154 24,647 16,512
Basic Shares 8,073 5,180 3,687 1,029

Earnings Calls

Quarter EPS
2024-03-31 -$0.65
2023-12-31 -$0.66
2023-09-30 -$0.65
2023-06-30 -$0.50